Theorem Clinical Research, a US-headquartered global contract research organisation (CRO) has appointed Scott Treiber to spearhead biopharmaceutical development as Executive Vice President and General Manager.
Treiber, an industry veteran with experience at many of the top global CROs, will oversee all aspects of Theorem’s biopharmaceutical development, including early phase first-in-human and proof-of-concept studies and Phase II–IV studies across a range of therapeutic areas.
Before joining Theorem, Treiber held executive-level positions within the CRO and pharma industries. He is a founding member of the Clinical Research Exchange and is active in the Chicagoland Chapter of the Association of Clinical Research Professionals.
